Medicover AB (publ) (MCOV-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr980.72 Million ≈ $105.54 Million USD) by net assets (Skr5.76 Billion ≈ $619.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medicover AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Medicover AB (publ) - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Medicover AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medicover AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medicover AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dongfeng Automobile Co Ltd
SHG:600006
|
0.072x |
|
Dime Community Bancshares, Inc.
NYSE:DCOM
|
0.032x |
|
Zhejiang Medicine Co Ltd
SHG:600216
|
0.061x |
|
Zymeworks Inc. Common Stock
NASDAQ:ZYME
|
-0.098x |
|
Jiangsu Provincial Agricultural Reclamation and Development Co Ltd
SHG:601952
|
0.011x |
|
PC Connection Inc
NASDAQ:CNXN
|
0.015x |
|
Jiangsu Evergreen New Material Technology Inc. Co. A
SHG:603125
|
N/A |
|
Taysha Gene Therapies Inc
NASDAQ:TSHA
|
-0.193x |
Annual Cash Flow Conversion Efficiency for Medicover AB (publ) (2005–2024)
The table below shows the annual cash flow conversion efficiency of Medicover AB (publ) from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see MCOV-B stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr489.30 Million ≈ $52.66 Million |
Skr261.90 Million ≈ $28.18 Million |
0.535x | +37.94% |
| 2023-12-31 | Skr528.30 Million ≈ $56.85 Million |
Skr205.00 Million ≈ $22.06 Million |
0.388x | +16.46% |
| 2022-12-31 | Skr510.80 Million ≈ $54.97 Million |
Skr170.20 Million ≈ $18.32 Million |
0.333x | -13.57% |
| 2021-12-31 | Skr562.10 Million ≈ $60.49 Million |
Skr216.70 Million ≈ $23.32 Million |
0.386x | +19.49% |
| 2020-12-31 | Skr483.50 Million ≈ $52.03 Million |
Skr156.00 Million ≈ $16.79 Million |
0.323x | +32.94% |
| 2019-12-31 | Skr359.70 Million ≈ $38.71 Million |
Skr87.30 Million ≈ $9.39 Million |
0.243x | +77.05% |
| 2018-12-31 | Skr323.90 Million ≈ $34.86 Million |
Skr44.40 Million ≈ $4.78 Million |
0.137x | -17.15% |
| 2017-12-31 | Skr304.00 Million ≈ $32.72 Million |
Skr50.30 Million ≈ $5.41 Million |
0.165x | -36.88% |
| 2016-12-31 | Skr98.80 Million ≈ $10.63 Million |
Skr25.90 Million ≈ $2.79 Million |
0.262x | -14.87% |
| 2015-12-31 | Skr93.20 Million ≈ $10.03 Million |
Skr28.70 Million ≈ $3.09 Million |
0.308x | +28.43% |
| 2014-12-31 | Skr90.50 Million ≈ $9.74 Million |
Skr21.70 Million ≈ $2.34 Million |
0.240x | +14.91% |
| 2005-12-31 | Skr23.55 Million ≈ $2.53 Million |
Skr4.91 Million ≈ $528.82K |
0.209x | -- |
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more